67
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer

, , , , &
Pages 2329-2337 | Published online: 01 Sep 2015

References

  • GuillemJGChessinDBCohenAMLong-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancerAnn Surg200524182983615849519
  • YoungAReaATreatment of advanced diseaseBMJ20003211278128111082094
  • OhSYKimYBPaekOJSuhKWContiguous invasion per se does not affect prognosis in colon cancerJ Surg Oncol200999717418937290
  • WillettCGRodriguez-BigasMARyanDPTreatment of locally advanced unresectable or recurrent rectal cancer Available from: http://www.uptodate.com/contents/treatment-of-locally-advanced-unresectable-or-recurrent-rectal-adenocarcinomaAccessed May 10, 2015
  • American Joint Committee on CancerAJCC Cancer Staging Manual6th edNew York, NY, USASpringer2002
  • CurleySAEvansDBAmesFCResection for cure of carcinoma of the colon directly invading the duodenum or pancreatic headJ Am Coll Surg19941795875927952464
  • PolkHCJrExtended resection for selected adenocarcinomas of the large bowelAnn Surg19721758928994260512
  • PittamMRThorntonHEllisHSurvival after extended resection for locally advanced carcinomas of the colon and rectumAnn R Coll Surg Engl19846681846703633
  • de WiltJHVermaasMFerenschildFVerhoefCManagement of locally advanced primary and recurrent rectal cancerClin Colon Rectal Surg20072025526320011207
  • MantovaniARomeroPPaluckaAKTumor immunity: effector response to tumor and role of the microenvironmentLancet200837177178318275997
  • VakillaJLotzeMTInflammation and necrosis promote tumor growthNat Cancer Rev20044641648
  • MunkholmPReview article: the incidence and prevalence of colorectal cancer in inflammatory bowel diseaseAliment Pharmacol Ther200318Suppl 21512950413
  • OkadaFKawaguchiTHabelhahHConversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude miceLab Invest2000801617162811092522
  • BaronJAColeBFSandlerRSA randomized trial of aspirin to prevent colorectal adenomasN Engl J Med200334889189912621133
  • BaronJAEpidemiology of non-steroidal anti-inflammatory drugs and cancerProg Exp Tumor Res20033712412795046
  • HulsGKoornstraJJKleibeukerJHNon-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomasLancet200336223023212885487
  • CoussensLMWerbZInflammation and cancerNature200242086086712490959
  • GabayCKushnerIAcute-phase proteins and other systemic responses to inflammationN Engl J Med19993404484549971870
  • DurdeyPWilliamsNSBrownDASerum carcinoembryonic antigen and acute phase reactant proteins in the pre-operative detection of fixation of colorectal tumoursBr J Surg1984718184
  • MercerDWTalamoTSMultiple markers of malignancy in sera of patients with colorectal carcinoma: preliminary clinical studiesClin Chem198531182418282414037
  • McMillanDCWotherspoonHAFearonKCMcArdleCSA prospective study of tumor recurrence and acute-phase response after apparently curative colorectal cancerAm J Surg19951703193227573721
  • NozoeTMatsumataTKitamuraMSugimachiKSignificance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancerAm J Surg19981763353389817250
  • WigmoreSJMcMahonAJSturgeonCMFearonKCAcute-phase protein response, survival and tumour recurrence in patients with colorectal cancerBr J Surg20018825526011167877
  • ChungYCChangYFSerum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicatorEur J Gastroenterol Hepatol20031536937312655256
  • ChungYCChangYFSerum interleukin-6 levels reflect the disease status of colorectal cancerJ Surg Oncol20038322222612884234
  • KinoshitaTItoHMikiCSerum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinomaCancer1999852526
  • YuceyarSErtukSDiricanACengizASanerHThe role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19–9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical studyInt Surg1996811361398912078
  • ErlingerTPPlatzEARifaiNHelzlsouerKJC-reactive protein and the risk of incident colorectal cancerJAMA20042958559014762037
  • KoWFHelzlsouerKJComstockGWSerum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancerJ Natl Cancer Inst199486187418757990163
  • Il’yasovaDColbertLHHarrisTBCirculating levels of inflammatory markers and cancer risk in the health aging and body composition cohortCancer Epidemiol Biomarkers Prev2005142413241816214925
  • GalonJCostesASanchez-CaboFType, density, and location of immune cells within human colorectal tumors predict clinical outcomeScience20063131960196417008531
  • KlintrupKMakinenJMKauppilaSInflammation and prognosis in colorectal cancerEur J Cancer2005412645265416239109
  • JassJRAjikokaYAllenJPAssessment of invasive growth pattern and lymphocytic infiltration in colorectal cancerHistopathology1996285435488803598
  • JassJRLoveSBNorthoverJMA new prognostic classification of rectal cancerLancet19871130313062884421
  • ShephardEGAndersonRRosenOPeptides generated from C-reactive protein by a neutrophil membrane protease. Amino acid sequence and effects of peptides on neutrophil oxidative metabolism and chemotaxisJ Immunol19901455146914762166760
  • McArdleCSMcKeeRFFindlayIGWotherspoonHHoleDJImprovement insurvival following surgery for colorectal cancerBr J Surg2005921008101315931658
  • FigueredoACoombesMEMukherjeeSAdjuvant therapy for completely resected Stage II colon cancerCochrane Database Syst Rev20083CD00539018646127
  • MorrisEJMaughanNJFormanDQuirkePWho to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathologyGut2007561419142517494107
  • IshizukaMNagataHTakagiKInflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancerAnn Surg20072461047105118043109
  • ForrestLMMcMillanDCMcArdleCSEvaluation of cumulative prognostic scores based on the systemic inflammatory response in patient inoperable non-small-cell lung cancerBr J Cancer2003891028103012966420
  • RoxburghCSSalmondJMHorganPGOienKAMcMillanDCComparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancerAnn Surg200924978879319387324
  • CrozierJEMckeeRFMcArdleCSThe presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancerBr J Cancer2006941833183616721360